Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis

Background: Colon adenocarcinoma (COAD) is still the main cause of cancer deaths worldwide. Although immunotherapy has made progress in recent years, there is still a need to improve diagnosis, prognosis, and treatment tools. UL-16 binding protein 1 (ULBP1) is a ligand that activates the receptor na...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Guo-Tian, Xie, Hai-Lun, Zhu, Li-Chen, Ge, Yi-Zhong, Yan, Lin, Liao, Cun, Gong, Yi-Zhen, Shi, Han-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862730/
https://www.ncbi.nlm.nih.gov/pubmed/35211154
http://dx.doi.org/10.3389/fgene.2022.762514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862730/
https://www.ncbi.nlm.nih.gov/pubmed/35211154
http://dx.doi.org/10.3389/fgene.2022.762514

Ejemplares similares